NDC 16571-692-01
CARBIDOPA, LEVODOPA AND ENTACAPONE 31.25 mg/1
CARBIDOPA, LEVODOPA AND ENTACAPONE · TABLET, FILM COATED
This is a prescription tablet that combines three medications to treat Parkinson's disease by helping to increase dopamine levels in the brain and extend the effectiveness of levodopa. The combination works by preventing the breakdown of levodopa, allowing it to remain active in the body longer.
Key Facts
- Brand Name
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- Generic Name
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- NDC Code (Package)
16571-692-01- NDC Code (Product)
16571-692- Manufacturer
- Rising Pharma Holdings, Inc.
- Strength
- 31.25 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA213212
- Drug Class
- Aromatic Amino Acid [EPC]; Catechol-O-Methyltransferase Inhibitor [EPC]
- Marketing Start
- 08/05/2021
Recall History
No Recall HistoryView Full Drug Page
CARBIDOPA, LEVODOPA AND ENTACAPONE — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.